Overview

Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the response rate of gemcitabine, cisplatin and erlotinib in metastatic pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Gyeongsang National University Hospital
Collaborators:
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Dong-A University Hospital
Treatments:
Cisplatin
Erlotinib Hydrochloride
Gemcitabine